Patients with mucous membrane pemphigoid to be closely monitored for vision impairment: JAMA Medha Baranwal2 Feb 2023 8:00 PM ISTGermany: In patients with mucous membrane pemphigoid (MMP), dermatologists should be aware of the risk factors and treatment strategies for the...
Isothiazolinone allergy in Europe on decline but rising in USA due to differences in regulation: JAMA Medha Baranwal31 Jan 2023 8:00 PM ISTUSA: A recent study published in JAMA Dermatology suggests that isothiazolinone allergy is decreasing in Europe, whereas allergy continues to increase...
Blue light therapy decreases lesion count and alleviates itch in Grover disease patients Dr.Niharika Harsha B20 Jan 2023 8:00 PM ISTChicago, IL: A new research found that blue light therapy decreases lesion count and alleviates itch in patients with Grover disease. The study was...
Novel 2-photon fluorescence microscopy imaging system could mean near-instant biopsy results Dr. Kamal Kant Kohli9 Jan 2023 8:00 PM ISTMedicine has advanced dramatically during the last century. But when it comes to getting biopsy results, very little has changed. Consider, for...
Presence of ARAs no contraindication to reinfusion of rituximab in pemphigus patients: JAMA Medha Baranwal19 Dec 2022 8:00 PM ISTFrance: Antirituximab antibodies (ARAs) are frequently detected in pemphigus patients treated with rituximab (RTX) and do not influence patients'...
Use of PPIs tied to drug-induced lupus erythematosus:JAMA Medha Baranwal16 Dec 2022 8:00 PM ISTFrance: Proton pump inhibitors (PPIs) are linked with pharmacovigilance signals for the occurrence of drug-induced lupus erythematosus (DILE), states...
Some Nutritional supplements have potential role in treatment of hair loss: JAMA Dr. Shravani Dali14 Dec 2022 8:00 PM ISTDespite the widespread use of nutritional supplements and dietary interventions for treating hair loss, the safety and effectiveness of available...
Researchers propose identifying TMP-SMX hypersensitivity reactions as SCoRCH: JAMA Medha Baranwal1 Dec 2022 12:15 PM ISTUSA: In a recent retrospective case series published in JAMA Dermatology, the researchers have described the mucocutaneous findings and clinical...
Two-photon fluorescence microscopy can be a diagnostic alternative for nonmelanoma skin cancers: JAMA Jacinthlyn Sylvia31 Oct 2022 3:00 AM ISTA new study conducted by Vincent D. Ching-Roa and team it was shown that the fact that two-photon fluorescence microscopy (TPFM) is capable of...
Sunburns during lifetime, particularly during childhood, tied to increased risk of skin cancer: JAMA Medha Baranwal17 Oct 2022 7:30 PM ISTNorway: High sunburn throughout life is associated with an increased risk of cutaneous melanoma and squamous cell carcinoma (cSCC) and melanoma,...
JAMA study reports drug-induced lupus erythematosus in users of proton pump inhibitors Medha Baranwal23 Sept 2022 8:30 PM ISTFrance: In case of suspected cases of drug-induced lupus erythematosus (DILE), proton pump inhibitors (PPIs) should be considered as a potential...
No risk of VTE in Eczema Patients Receiving JAK Inhibitors: Study Dr. Shravani Dali17 Sept 2022 10:00 AM ISTThere is no risk for venous thromboembolism in Eczema Patients Receiving JAK Inhibitors suggests a new study published in the JAMA Dermatology. ...
